Sarepta Therapeutics (SRPT) Special Call - Slideshow
Sarepta Therapeutics(SRPT)2020-12-11 21:15| --- | --- | --- | --- | |-------------------------------|-----------------------------------------------------------------------------------------------------|----------------------------------------------------------|-------| | | | | | | | | | | | | Clinical Update: MOMENTUM MultipleAscending Dose Study of SRP-5051 for Duchenne Muscular Dystrophy | | | | | | | | | DOUG INGRAM | GILMORE O'NEILL , MB, MMSC | | | | President and CEO | Executive Vice President, R&D and Chief Medical Officer | | | | December ...